Pediatric acute lymphoblastic leukemia: There is no TEL-ing what wonders lie ahead

Posted by rob on February 25, 2010 under Uncategorized | Comments are off for this article

The advent of molecular medicine has allowed physicians and scientists to decipher some of nature’s mysteries. Few stories are more exhilarating than that of the successes in pediatric acute lymphoblastic leukemia (ALL) and chronic myelogenous leukemia (CML). Indeed, children with ALL are now curable without the need for cranial radiation and imatinib mesylate has changed the landscape of CML therapy . Despite these advances disease recurrence and adverse late effects continue to dampen our celebrations. Enticing dormant cancer stem cells to undergo mitosis and offering risk-directed therapy are current endeavors aimed to overcome these obstacles. (Source: Leukemia Research)
More